9,347 Shares in HCP, Inc. (NYSE:HCP) Purchased by Campbell & CO Investment Adviser LLC

Campbell & CO Investment Adviser LLC purchased a new stake in HCP, Inc. (NYSE:HCP) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 9,347 shares of the real estate investment trust’s stock, valued at approximately $293,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in HCP. Atlas Brown Inc. boosted its holdings in HCP by 3.4% in the first quarter. Atlas Brown Inc. now owns 10,011 shares of the real estate investment trust’s stock valued at $313,000 after purchasing an additional 327 shares during the last quarter. Moody National Bank Trust Division boosted its stake in shares of HCP by 0.9% during the 1st quarter. Moody National Bank Trust Division now owns 38,921 shares of the real estate investment trust’s stock worth $1,218,000 after acquiring an additional 329 shares in the last quarter. Bessemer Group Inc. boosted its stake in shares of HCP by 32.9% during the 4th quarter. Bessemer Group Inc. now owns 1,332 shares of the real estate investment trust’s stock worth $37,000 after acquiring an additional 330 shares in the last quarter. JOYN Advisors Inc. boosted its stake in shares of HCP by 26.4% during the 4th quarter. JOYN Advisors Inc. now owns 1,740 shares of the real estate investment trust’s stock worth $49,000 after acquiring an additional 363 shares in the last quarter. Finally, Fort Washington Investment Advisors Inc. OH boosted its stake in shares of HCP by 1.2% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 32,640 shares of the real estate investment trust’s stock worth $912,000 after acquiring an additional 400 shares in the last quarter. Hedge funds and other institutional investors own 95.47% of the company’s stock.

In related news, Director Christine Garvey sold 3,405 shares of HCP stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $29.80, for a total transaction of $101,469.00. Following the sale, the director now directly owns 5,348 shares in the company, valued at approximately $159,370.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.13% of the stock is owned by company insiders.

Shares of HCP stock traded down $0.41 during trading on Monday, hitting $31.57. 3,513,203 shares of the stock were exchanged, compared to its average volume of 3,174,127. The company has a market cap of $15.29 billion, a PE ratio of 17.35, a price-to-earnings-growth ratio of 6.95 and a beta of 0.31. The business’s 50-day simple moving average is $31.71. HCP, Inc. has a 12-month low of $24.47 and a 12-month high of $33.58. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.90.

HCP (NYSE:HCP) last released its quarterly earnings data on Wednesday, May 1st. The real estate investment trust reported $0.44 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.43 by $0.01. The business had revenue of $436.15 million during the quarter, compared to analysts’ expectations of $442.20 million. HCP had a net margin of 59.96% and a return on equity of 18.05%. The company’s revenue for the quarter was down 9.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.48 EPS. On average, equities analysts forecast that HCP, Inc. will post 1.74 earnings per share for the current year.

Several equities research analysts have recently issued reports on HCP shares. Zacks Investment Research raised shares of HCP from a “sell” rating to a “hold” rating in a research note on Thursday, March 14th. Morgan Stanley set a $32.00 price target on shares of HCP and gave the company a “hold” rating in a research note on Thursday, March 28th. TheStreet lowered shares of HCP from a “b-” rating to a “c+” rating in a research note on Tuesday, May 7th. Raymond James raised shares of HCP from a “market perform” rating to an “outperform” rating and set a $35.00 price target on the stock in a research note on Thursday, June 13th. Finally, KeyCorp raised their price target on shares of HCP from $32.00 to $34.00 and gave the company an “overweight” rating in a research note on Monday. Four analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $30.41.

About HCP

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

See Also: What are gap-up stocks?

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.